TITLE

COPD: rehabilitation and oxygen

PUB. DATE
December 2004
SOURCE
Thorax;Dec2004 Supplement, Vol. 59, p59
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
The article presents some papers related to pulmonary rehabilitation for patients with stable chronic obstructive pulmonary disease (COPD). The effects of a 7 week outpatient pulmonary rehabilitation program on exercise capacity and health status in a group of non-COPD patients with chronic respiratory impairment and a matched group of COPD patients were investigated. In total, 20 patients referred for pulmonary rehabilitation with a primary diagnosis other than COPD were recruited (non-COPD group), and 20 COPD patients matched for age, sex, and baseline exercise capacity were also recruited as a control group.
ACCESSION #
17564529

 

Related Articles

  • Conference brief: GORD more likely in COPD.  // GP: General Practitioner;9/13/2004, p15 

    The article reports that a small study of 54 patients with COPD and 13 controls with respiratory complaints not meeting a COPD diagnosis, has found a higher prevalence of gastro-oesophageal reflux disease in those with COPD, 30 per cent compared with 23 per cent of controls.

  • Understanding wasted/ineffective efforts in mechanically ventilated COPD patients using the Campbell diagram. Vassilakopoulos, Theodoros // Intensive Care Medicine;Jul2008, Vol. 34 Issue 7, p1336 

    The article focuses on the study of wasted of ineffective efforts in mechanically ventilated chronic obstructive pulmonary disease (COPD) patients using the Campbell diagram. It explores the process of constructing the Campbell diagram. Several questions considered in the study are discussed,...

  • COPD combination benefits questioned. Tanday, Sanjay // GP: General Practitioner;10/30/2009, p11 

    The article presents information on findings of a research study which show that combination therapy does not offer additional benefits in lung disease. According to the Danish research, corticosteroid therapy and using long-acting beta- agonists (LABAs) for COPD does not offer additional benefits.

  • Systemic Corticosteroid Use in COPD Exacerbation. Miller, Karl E. // American Family Physician;10/15/2001, Vol. 64 Issue 8, p1419 

    Presents information on a study by A. Sayiner and others that compared the efficacy of three-day and 10-day courses of methylprednisolone in the treatment of acute chronic obstructive pulmonary disease exacerbations. Description of the study and its results; Conclusion that in patients with an...

  • Evidence for Management of COPD Exacerbations. Miller, Karl E. // American Family Physician;11/1/2001, Vol. 64 Issue 9, p1614 

    Presents information on the collaboration between the American College of Physicians-American Society of Internal Medicine and the American College of Chest Physicians to develop an evidence-based clinical practice guideline for the management of acute exacerbations in chronic obstructive...

  • Diagnosing COPD.  // Thorax;Mar2004 Supplement 1, Vol. 59, p27 

    The article focuses on the diagnosis of chronic obstructive pulmonary disease (COPD), a heterogeneous disease that affects different patients in different ways. It also discusses various symptoms and signs of the disease and also the conditions which present with similar symptoms as COPD....

  • The differences between asthma & COPD. Booker, Rachel // Practice Nurse;7/25/2003, Vol. 26 Issue 2, p36 

    Differentiates the asthma from chronic obstructive pulmonary disease. Comparison of treatment goals; Symptoms; History; Differential diagnosis.

  • Reversibility testing is 'vital' in COPD patients.  // GP: General Practitioner;9/13/2004, p5 

    The article reports that reversibility testing of patients with COPD is essential, according to Great Britain research presented at last week's European Respiratory Society Congress in Glasgow. NICE has advised that reversibility testing is not always necessary to exclude asthma in patients with...

  • ExhaIed breath: can we identify inflammation?  // Thorax;Dec2003 Supplement 3, Vol. 58, piii35 

    Airway inflammation has a central role in the development and progression of chronic obstructive pulmonary disease (COPD) and bronchiectasis. Both pro-and anti-inflammatory mediators may control the inflammaibry response in airway disease. The aim of the study was to measure inflammatory...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics